Author Mavropoulou, Eirini
-
2018 | Journal Article
Direct assessment of adherence and drug interactions in patients with hypertensive crisis-A cross-sectional study in the Emergency Department
Wallbach, M. ; Lach, N.; Stock, J. ; Hiller, H.; Mavropoulou, E.; Chavanon, M.-L. & Neurath, H. et al. (2018)
Journal of Clinical Hypertension, 21(1) pp. 55-63. DOI: https://doi.org/10.1111/jch.13448
Details DOI
-
2018 | Journal Article |
The "rapid atrial swirl sign" for assessing central venous catheters: Performance by medical residents after limited training.
Korsten, P. ; Mavropoulou, E.; Wienbeck, S. ; Ellenberger, D. ; Patschan, D.; Zeisberg, M. & Vasko, R. et al. (2018)
PloS one, 13(7) pp. e0199345-e0199345. DOI: https://doi.org/10.1371/journal.pone.0199345
Details DOI PMID PMC
-
2019 | Journal Article |
Cytomegalovirus colitis in inflammatory bowel disease and after haematopoietic stem cell transplantation: diagnostic accuracy, predictors, risk factors and disease outcome
Mavropoulou, E.; Ternes, K.; Mechie, N.-C.; Bremer, S. C. B.; Kunsch, S.; Ellenrieder, V. & Neesse, A. et al. (2019)
BMJ Open Gastroenterology, 6(1) art. e000258. DOI: https://doi.org/10.1136/bmjgast-2018-000258
Details DOI
-
2019 | Journal Article |
Impact of faecal calprotectin measurement on clinical decision-making in patients with Crohn’s disease and ulcerative colitis
Bathe, A. L.; Mavropoulou, E.; Mechie, N.-C.; Petzold, G. ; Ellenrieder, V. ; Kunsch, S. & Amanzada, A. (2019)
PLoS One, 14(10) pp. e0223893. DOI: https://doi.org/10.1371/journal.pone.0223893
Details DOI
-
2019 | Journal Article |
Serum vitamin D but not zinc levels are associated with different disease activity status in patients with inflammatory bowel disease
Mechie, N.-C.; Mavropoulou, E.; Ellenrieder, V. ; Petzold, G. ; Kunsch, S.; Neesse, A. & Amanzada, A. (2019)
Medicine, 98(15) art. e15172. DOI: https://doi.org/10.1097/MD.0000000000015172
Details DOI PMID PMC
-
2020 | Journal Article
Distinct Association of Serum Vitamin D Concentration with Disease Activity and Trough Levels of Infliximab and Adalimumab during Inflammatory Bowel Disease Treatment
Mechie, N.-C.; Mavropoulou, E.; Ellenrieder, V. ; Kunsch, S.; Cameron, S. & Amanzada, A. (2020)
Digestion, 101(6) pp. 761-770. DOI: https://doi.org/10.1159/000502515
Details DOI
-
2020 | Journal Article |
Association of serum interleukin-6 and soluble interleukin-2-receptor levels with disease activity status in patients with inflammatory bowel disease: A prospective observational study
Mavropoulou, E.; Mechie, N.-C.; Knoop, R. ; Petzold, G. ; Ellenrieder, V. ; Kunsch, S. & Pilavakis, Y. et al. (2020)
PLoS One, 15(5) pp. e0233811. DOI: https://doi.org/10.1371/journal.pone.0233811
Details DOI
-
2021 | Journal Article |
Evaluation of ustekinumab trough levels during induction and maintenance therapy with regard to disease activity status in difficult to treat Crohn disease patients
Mechie, N.-C.; Burmester, M.; Mavropoulou, E.; Pilavakis, Y.; Kunsch, S.; Ellenrieder, V. & Amanzada, A. (2021)
Medicine, 100(11) pp. e25111. DOI: https://doi.org/10.1097/MD.0000000000025111
Details DOI
-
2021 | Journal Article | Research Paper |
Enhancer of Zeste Homolog 2 in Colorectal Cancer Development and Progression
Bremer, S. C. B.; Mechie, N.-C.; Mavropoulou, E.; Ellenrieder, V.; Hessmann, E. ; Conradi, L.-C. & Amanzada, A. et al. (2021)
Digestion, 102(2) pp. 227-235. DOI: https://doi.org/10.1159/000504093
Details DOI PMID PMC